Invesco Oppenheimer Global Opp R5 (GOFFX)

69.21 -0.48  -0.69% Aug 7 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 69.21
Turnover Ratio 3.00%
1 Year Fund Level Flows -1.569B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 9.25% 6.20% 22
3M 25.04% 23.46% 23
6M 13.07% -0.89% 11
YTD 12.81% 0.34% 21
1Y 29.04% 13.08% 22
3Y -- 6.10% --
5Y -- 7.01% --
10Y -- 8.56% --
15Y -- 7.03% --
20Y -- 5.91% --
As of Aug. 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 1.51% 1.51% 0.00%
Stock 98.49% 98.49% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 50.47%
North America 50.47%
Latin America 0.00%
Greater Europe 36.86%
United Kingdom 11.55%
Europe Developed 24.36%
Europe Emerging 0.00%
Africa/Middle East 0.94%
Greater Asia 12.68%
Japan 12.27%
Australasia 0.00%
Asia Developed 0.41%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets --
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 1.00%
Communication Services 3.88%
Consumer Cyclical 9.00%
Consumer Defensive 1.79%
Energy 0.00%
Financial Services 0.78%
Healthcare 35.07%
Industrials 10.31%
Real Estate 0.00%
Technology 38.16%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 0.99%
Large 17.56%
Medium 35.72%
Small 35.62%
Micro 10.11%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 0.14%
Large Cap Blend 3.25%
Large Cap Growth 15.40%
Mid Cap Value 3.44%
Mid Cap Blend 3.74%
Mid Cap Growth 28.84%
Small Cap Value 4.25%
Small Cap Blend 16.26%
Small Cap Growth 24.68%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics 11.04% 21.85 +1.58%
AMD Advanced Micro Devices Inc 7.55% 84.85 -2.15%
EXAS Exact Sciences Corp 2.67% 86.69 -4.10%
2413 M3 Inc 2.18% -- --
4587 PeptiDream Inc 1.93% -- --
QCOM Qualcomm Inc 1.87% 108.25 -2.53%
NVRO Nevro Corp 1.84% 141.06 -0.50%
ERF Eurofins Scientific SE 1.83% -- --
ARWR Arrowhead Pharmaceuticals Inc 1.59% 40.23 -1.93%
AFX Carl Zeiss Meditec AG 1.43% -- --
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks capital appreciation. The fund invests mainly in equity securities of issuers in the U.S. and foreign countries. It currently emphasizes investments in equities, but it may also invest in debt securities and may invest up to 25% of its assets in "below-investment-grade" securities, commonly known as "junk bonds." The fund typically invests in a number of different countries and can invest in any country, including countries with developing or emerging markets. It invests a substantial portion of its assets in small- and mid-sized companies.
General
Security Type Mutual Fund
Oldest Share Symbol OPGIX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name World Small/Mid Stock
Prospectus Objective World Stock
Fund Owner Firm Name Invesco
Benchmark Index
MSCI ACWI NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Frank Jennings 24.77 yrs

Share Classes

Symbol Share Class
OGICX C
OGIIX Inst
OGINX Retirement
OGIYX Inst
OPGIX A

Net Fund Flows

1M -89.49M
3M -253.24M
6M -752.17M
YTD -867.83M
1Y -1.569B
3Y 419.43M
5Y 925.87M
10Y 186.98M
As of July 31, 2020

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.7742
Daily Value at Risk (VaR) 1% (All) 8.13%
Monthly Value at Risk (VaR) 1% (All) 34.45%

Fundamentals

Dividend Yield TTM (8-7-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield (7-29-20) 0.00%
Weighted Average PE Ratio 29.12
Weighted Average Price to Sales Ratio 1.494
Weighted Average Price to Book Ratio 2.901
Weighted Median ROE 2.24%
Weighted Median ROA -0.72%
Forecasted Dividend Yield 0.92%
Forecasted PE Ratio 26.17
Forecasted Price to Sales Ratio 1.167
Forecasted Price to Book Ratio 2.155
Number of Holdings 126
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 14.15%
Forecasted Book Value Growth 5.74%
Forecasted Cash Flow Growth 4.50%
Forecasted Earnings Growth 137.4%
Forecasted Revenue Growth -0.78%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 1.00M USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.66%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/24/2019
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 1/28/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.